Search Results 431-440 of 11666 for Drug-resistant TB
... treatment period followed by a 24-week observation period. The primary objective of this study is to assess the proportion of treatment-resistant subjects ...
The purpose of this study is to to determine the safety and effectivness of a single dose of autologous polyTregs or darTregs in renal transplant recipients ...
... treatment-resistant relapsing multiple sclerosis (MS). ... Each episode of treatment failure must occur following ≥ 3 months of treatment ... TB Gold or TB Gold ...
The primary purpose of this study is to examine the effects of abemaciclib on the CD8/FOXP3 ratio in chemotherapy-resistant triple negative breast cancer (TNBC) ...
The only drug currently approved for IBS-D is alosetron, a 5-HT3 antagonist that may relieve abdominal pain and slow colonic and small bowel transit. Alosetron ...
Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use Program Antimicrob Agents ...
The purpose of this study is to establish preliminary evidence of the effiectiveness, safety, and tolerability of LB1148 for the treatment of post-operative ...
Drugs and Supplements · Find a drug by its first letter · T- · Ta · Tb · Tc · Te · Th · Ti.
Many of us don't get that much, and that can have serious consequences. On the next Mayo Clinic Radio, sleep medicine specialist Dr. Timothy Morgenthaler ...
Initiation of treatment of AD with ... [TB]*, histoplasmosis, listeriosis ... History of alcohol or drug abuse within 2 years of the screening visit.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.